Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Purple Biotech
Deal Size : $101.0 million
Deal Type : Acquisition
Details : The acquisition will provide Purple Biotech with an expanded portfolio of investigational tri-specific antibody compounds that target multiple antigens and offer the potential to further expand to additional targets.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : $3.5 million
February 02, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Purple Biotech
Deal Size : $101.0 million
Deal Type : Acquisition
Reset All
